CD BioSciences Expands Anti-Aging Drug Development Services

Biotech firm aims to accelerate novel therapeutic discovery for longevity research.

Mar. 30, 2026 at 6:09pm

Got story updates? Submit your updates here. ›

An abstract, highly textured painting in earthy tones of green, brown, and blue, featuring sweeping geometric shapes and precise botanical spirals, representing the complex natural forces involved in the aging process.A conceptual illustration captures the intricate biological mechanisms underlying the aging process, hinting at the potential for novel therapeutic interventions to extend healthy lifespans.NYC Today

CD BioSciences, a leading preclinical research services provider, has announced the expansion of its comprehensive anti-aging drug development capabilities to support global efforts in discovering novel therapeutic interventions for longevity.

Why it matters

As the world's population continues to age, there is a growing demand for innovative solutions to combat age-related diseases and extend healthy lifespans. CD BioSciences' expanded services aim to catalyze advancements in this critical area of biomedical research.

The details

The company's anti-aging drug development services cover a wide range of in vitro and in vivo studies, including compound screening, pharmacokinetics, pharmacodynamics, and preclinical efficacy and safety evaluations. By offering these integrated capabilities, CD BioSciences seeks to streamline the discovery and development of novel anti-aging therapeutics for its global client base.

  • CD BioSciences announced the expansion of its anti-aging drug development services on March 30, 2026.

The players

CD BioSciences

A leading preclinical research services provider focused on accelerating the discovery and development of novel therapeutic interventions.

Got photos? Submit your photos here. ›

What’s next

CD BioSciences plans to showcase its expanded anti-aging drug development capabilities at the upcoming International Conference on Aging and Longevity in June 2026.

The takeaway

With its comprehensive suite of anti-aging drug development services, CD BioSciences aims to support researchers and pharmaceutical companies in their efforts to develop groundbreaking therapies that can help address the global challenge of population aging.